Invention Grant
- Patent Title: Raf inhibitor compounds
- Patent Title (中): Raf抑制剂化合物
-
Application No.: US13785575Application Date: 2013-03-05
-
Publication No.: US08741911B2Publication Date: 2014-06-03
- Inventor: Matthew Carl Allgeier , Daniel L. Flynn , Michael D. Kaufman , Phenil J. Patel , Craig D. Wolfangel
- Applicant: Eli Lilly and Company , Deciphera Pharmaceuticals, LLC
- Applicant Address: US IN Indianapolis US KS Lawrence
- Assignee: Eli Lilly and Company,Deciphera Pharmaceuticals, LLC
- Current Assignee: Eli Lilly and Company,Deciphera Pharmaceuticals, LLC
- Current Assignee Address: US IN Indianapolis US KS Lawrence
- Agent Danica Hostettler; John Demeter
- Main IPC: A01N43/90
- IPC: A01N43/90 ; A61K31/519 ; C07D471/00
Abstract:
The present invention provides a pyrido[2,3-d]pyrimidine compound, or a pharmaceutically acceptable salt thereof, that inhibits Raf and, therefore, may be useful in treating cancer.
Public/Granted literature
- US20130252977A1 Raf Inhibitor Compounds Public/Granted day:2013-09-26
Information query
IPC分类:
